Pharvision Advisers, LLC filed its 13F report for Q2 2026 on August 11, 2026. The portfolio totaled 5.3 M reflecting a +1528.58% change from the prior quarter, spanning 62 assets. The top 10 holdings comprised 23.9% of the portfolio, with Financials as the largest sector allocation. Quarterly activity included 60 new positions and 5 complete exits.
Items:
Total Value:
| Issuer Name | Class | Value | Shares | Option Type |
|---|
Pharvision Advisers submitted their Form 13F-HR for the Q2 2026 period on 08/11/2026. This was the only submission for the quarter.
In the Q2 2026 filing, Pharvision Advisers reported a managed portfolio value of 5.3 M, consisting of 62 individual positions.
This page displays the raw filing documents. To see which stocks Pharvision Advisers bought or sold during Q2 2026, please visit Pharvision Advisers's Portfolio Analysis page.